DRI Healthcare Trust

TO:DHT-U Canada Drug Manufacturers - Specialty & Generic
Market Cap
$648.25 Million
Market Cap Rank
#10772 Global
#36 in Canada
Share Price
$11.68
Change (1 day)
+0.00%
52-Week Range
$7.79 - $12.45
All Time High
$12.60
About

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

DRI Healthcare Trust - Asset Resilience Ratio

Latest as of March 2024: 13.91%

DRI Healthcare Trust (DHT-U) has an Asset Resilience Ratio of 13.91% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$125.67 Million
Cash + Short-term Investments
Total Assets
$903.45 Million
All company assets
Resilience Assessment
Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how DRI Healthcare Trust's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down DRI Healthcare Trust's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $125.67 Million 13.91%
Total Liquid Assets $125.67 Million 13.91%

Asset Resilience Insights

  • Moderate Liquidity: DRI Healthcare Trust has 13.91% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

DRI Healthcare Trust Industry Peers by Asset Resilience Ratio

Compare DRI Healthcare Trust's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for DRI Healthcare Trust (None–None)

The table below shows the annual Asset Resilience Ratio data for DRI Healthcare Trust.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points